1. Home
  2. VCEL vs HMN Comparison

VCEL vs HMN Comparison

Compare VCEL & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • HMN
  • Stock Information
  • Founded
  • VCEL 1989
  • HMN 1945
  • Country
  • VCEL United States
  • HMN United States
  • Employees
  • VCEL N/A
  • HMN N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • HMN Property-Casualty Insurers
  • Sector
  • VCEL Health Care
  • HMN Finance
  • Exchange
  • VCEL Nasdaq
  • HMN Nasdaq
  • Market Cap
  • VCEL 1.8B
  • HMN 1.8B
  • IPO Year
  • VCEL 1997
  • HMN 1991
  • Fundamental
  • Price
  • VCEL $36.28
  • HMN $45.17
  • Analyst Decision
  • VCEL Strong Buy
  • HMN Buy
  • Analyst Count
  • VCEL 6
  • HMN 5
  • Target Price
  • VCEL $58.60
  • HMN $46.75
  • AVG Volume (30 Days)
  • VCEL 563.8K
  • HMN 217.7K
  • Earning Date
  • VCEL 11-06-2025
  • HMN 11-04-2025
  • Dividend Yield
  • VCEL N/A
  • HMN 3.16%
  • EPS Growth
  • VCEL 2045.40
  • HMN 71.62
  • EPS
  • VCEL 0.13
  • HMN 3.38
  • Revenue
  • VCEL $249,119,000.00
  • HMN $1,649,200,000.00
  • Revenue This Year
  • VCEL $18.35
  • HMN $7.70
  • Revenue Next Year
  • VCEL $22.26
  • HMN $6.29
  • P/E Ratio
  • VCEL $272.85
  • HMN $13.09
  • Revenue Growth
  • VCEL 16.13
  • HMN 6.01
  • 52 Week Low
  • VCEL $29.24
  • HMN $36.20
  • 52 Week High
  • VCEL $63.00
  • HMN $47.81
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 56.70
  • HMN 54.11
  • Support Level
  • VCEL $33.76
  • HMN $43.80
  • Resistance Level
  • VCEL $37.00
  • HMN $45.45
  • Average True Range (ATR)
  • VCEL 1.48
  • HMN 0.93
  • MACD
  • VCEL 0.05
  • HMN 0.07
  • Stochastic Oscillator
  • VCEL 81.35
  • HMN 74.57

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

Share on Social Networks: